Michael Bennet actually said...
It would be much better to pay a flat fee that was representative of the true cost of administering the drug and a reasonable profit, rather than to have it be based on cost plus percent of cost.
Context
Bennet suggests a better payment model for chemotherapy drugs under Medicare.
12/11/2017